Incyte (INCY) Long-Term Deferred Tax (2017 - 2026)
Incyte (INCY) posted Long-Term Deferred Tax of $452.5 million for Q1 2026, down 12.18% on a QoQ basis from $515.3 million in Q4 2025, and down 41.15% year-over-year from $768.9 million in Q1 2025.
Incyte (INCY) Long-Term Deferred Tax (2017 - 2026) Analysis & Trends
Incyte's Long-Term Deferred Tax history runs 10 years deep, the most recent figure standing at $452.5 million for Q1 2026.
- Quarterly Long-Term Deferred Tax fell 41.15% year-over-year to $452.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $452.5 million (down 41.15% YoY) and the FY2025 annual result came in at $515.3 million, down 32.38% from the prior year.
- Long-Term Deferred Tax was $452.5 million for Q1 2026 at Incyte, down from $515.3 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $768.9 million in Q1 2025 and bottomed at $426.8 million in Q3 2022.
- A 5-year average of $579.2 million and a median of $532.5 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax soared 37.98% — and 2026, when it plunged 41.15%.
- Incyte's Long-Term Deferred Tax stood at $457.9 million in 2022, then surged by 37.98% to $631.9 million in 2023, then grew by 20.6% to $762.1 million in 2024, then sank by 32.38% to $515.3 million in 2025, then declined by 12.18% to $452.5 million in 2026.
- Business Quant data shows INCY's Long-Term Deferred Tax at $452.5 million in Q1 2026, $515.3 million in Q4 2025, and $528.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 452.52 Mn |
| Dec 31, 2025 | 515.29 Mn |
| Sep 30, 2025 | 528.14 Mn |
| Jun 30, 2025 | 652.28 Mn |
| Mar 31, 2025 | 768.90 Mn |
| Dec 31, 2024 | 762.07 Mn |
| Sep 30, 2024 | 762.31 Mn |
| Jun 30, 2024 | 729.56 Mn |
| Mar 31, 2024 | 666.57 Mn |
| Dec 31, 2023 | 631.89 Mn |
| Sep 30, 2023 | 564.39 Mn |
| Jun 30, 2023 | 532.51 Mn |
| Mar 31, 2023 | 494.75 Mn |
| Dec 31, 2022 | 457.94 Mn |
| Sep 30, 2022 | 426.84 Mn |
| Jun 30, 2022 | 434.87 Mn |
| Mar 31, 2022 | 465.37 Mn |
| Dec 31, 2021 | 467.54 Mn |
| Dec 31, 2020 | 2.05 Mn |
| Dec 31, 2019 | 1.65 Mn |